Jim Simons Indaptus Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 27,700 shares of INDP stock, worth $23,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,700
Previous 27,100
2.21%
Holding current value
$23,268
Previous $33,000
30.3%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INDP
# of Institutions
20Shares Held
638KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$215,2620.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$84,1470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA82.1KShares$68,9790.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$38,0820.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$36,8930.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $6.94M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...